370 related articles for article (PubMed ID: 36601121)
21. Long noncoding RNAs as regulators of cancer immunity.
Denaro N; Merlano MC; Lo Nigro C
Mol Oncol; 2019 Jan; 13(1):61-73. PubMed ID: 30499165
[TBL] [Abstract][Full Text] [Related]
22. The role of tumor microenvironment in development and progression of malignant melanomas - a systematic review.
Gurzu S; Beleaua MA; Jung I
Rom J Morphol Embryol; 2018; 59(1):23-28. PubMed ID: 29940608
[TBL] [Abstract][Full Text] [Related]
23. Long non-coding RNAs in cutaneous melanoma: clinical perspectives.
Hulstaert E; Brochez L; Volders PJ; Vandesompele J; Mestdagh P
Oncotarget; 2017 Jun; 8(26):43470-43480. PubMed ID: 28415644
[TBL] [Abstract][Full Text] [Related]
24. The current advances of lncRNAs in breast cancer immunobiology research.
Fonseca-Montaño MA; Vázquez-Santillán KI; Hidalgo-Miranda A
Front Immunol; 2023; 14():1194300. PubMed ID: 37342324
[TBL] [Abstract][Full Text] [Related]
25. The role of long non-coding RNAs in breast cancer microenvironment.
Yao W; Wang L; Liu F; Xia L
Pathol Res Pract; 2023 Aug; 248():154707. PubMed ID: 37506626
[TBL] [Abstract][Full Text] [Related]
26. Long noncoding RNAs in cancer-immunity cycle.
Yu WD; Wang H; He QF; Xu Y; Wang XC
J Cell Physiol; 2018 Sep; 233(9):6518-6523. PubMed ID: 29574911
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic Role of Exosomal Circular and Long Noncoding RNAs in Gastrointestinal Cancers.
Yun BD; Choi YJ; Son SW; Cipolla GA; Berti FCB; Malheiros D; Oh TJ; Kuh HJ; Choi SY; Park JK
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055115
[TBL] [Abstract][Full Text] [Related]
28. The role of long non-coding RNAs in mediating chemoresistance by modulating autophagy in cancer.
Jin KT; Lu ZB; Lv JQ; Zhang JG
RNA Biol; 2020 Dec; 17(12):1727-1740. PubMed ID: 32129701
[TBL] [Abstract][Full Text] [Related]
29. LncRNAs in tumor metabolic reprogramming and immune microenvironment remodeling.
Yang J; Liu F; Wang Y; Qu L; Lin A
Cancer Lett; 2022 Sep; 543():215798. PubMed ID: 35738332
[TBL] [Abstract][Full Text] [Related]
30. Whole transcriptome analysis reveals correlation of long noncoding RNA ZEB1-AS1 with invasive profile in melanoma.
Siena ÁDD; Plaça JR; Araújo LF; de Barros II; Peronni K; Molfetta G; de Biagi CAO; Espreafico EM; Sousa JF; Silva WA
Sci Rep; 2019 Aug; 9(1):11350. PubMed ID: 31383874
[TBL] [Abstract][Full Text] [Related]
31. The Emerging Role of EMT-related lncRNAs in Therapy Resistance and their Applications as Biomarkers.
Kichi ZA; Soltani M; Rezaei M; Shirvani-Farsani Z; Rojhannezhad M
Curr Med Chem; 2022; 29(26):4574-4601. PubMed ID: 35352644
[TBL] [Abstract][Full Text] [Related]
32. Regulatory effects of lncRNAs and miRNAs on the crosstalk between autophagy and EMT in cancer: a new era for cancer treatment.
Si L; Yang Z; Ding L; Zhang D
J Cancer Res Clin Oncol; 2022 Mar; 148(3):547-564. PubMed ID: 35083552
[TBL] [Abstract][Full Text] [Related]
33. Long noncoding RNAs in cancer immunity: a new avenue in drug discovery.
Dutta A; Roy A; Chatterjee S
Drug Discov Today; 2021 Jan; 26(1):264-272. PubMed ID: 32827755
[TBL] [Abstract][Full Text] [Related]
34. Roles of lncRNAs in cancer: Focusing on angiogenesis.
Jin KT; Yao JY; Fang XL; Di H; Ma YY
Life Sci; 2020 Jul; 252():117647. PubMed ID: 32275935
[TBL] [Abstract][Full Text] [Related]
35. The regulatory role of long non- coding RNAs as a novel controller of immune response against cancer cells.
Mofed D; Omran JI; Sabet S; Baiomy AA; Emara M; Salem TZ
Mol Biol Rep; 2022 Dec; 49(12):11775-11793. PubMed ID: 36207500
[TBL] [Abstract][Full Text] [Related]
36. miRNAs, Melanoma and Microenvironment: An Intricate Network.
Romano G; Kwong LN
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29112174
[TBL] [Abstract][Full Text] [Related]
37. Long non-coding RNAs as emerging regulators of epithelial to mesenchymal transition in gynecologic cancers.
Lin X; Qiu J; Hua K
Biosci Trends; 2018 Sep; 12(4):342-353. PubMed ID: 30146551
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA MYOSLID promotes invasion and metastasis by modulating the partial epithelial-mesenchymal transition program in head and neck squamous cell carcinoma.
Xiong HG; Li H; Xiao Y; Yang QC; Yang LL; Chen L; Bu LL; Zhang WF; Zhang JL; Sun ZJ
J Exp Clin Cancer Res; 2019 Jun; 38(1):278. PubMed ID: 31238980
[TBL] [Abstract][Full Text] [Related]
39. Noncoding RNAs as novel immunotherapeutic tools against cancer.
Kaur M; Kaur B; Konar M; Sharma S
Adv Protein Chem Struct Biol; 2022; 129():135-161. PubMed ID: 35305717
[TBL] [Abstract][Full Text] [Related]
40. Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.
Pi YN; Qi WC; Xia BR; Lou G; Jin WL
Front Immunol; 2021; 12():697083. PubMed ID: 34295338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
